Literature DB >> 34127686

Reconstruction of the miR-506-Quaking axis in Idiopathic Pulmonary Fibrosis using integrative multi-source bioinformatics.

Stevan D Stojanović1, Maximilian Fuchs2, Chunguang Liang2, Kevin Schmidt1, Ke Xiao1,3, Annette Just1, Angelika Pfanne1, Andreas Pich4, Gregor Warnecke5, Peter Braubach6,7, Christina Petzold6,7, Danny Jonigk6,7, Jörg H W Distler8, Jan Fiedler9,10,11, Thomas Thum12,13,14,15, Meik Kunz16.   

Abstract

The family of RNA-binding proteins (RBP) functions as a crucial regulator of multiple biological processes and diseases. However, RBP function in the clinical setting of idiopathic pulmonary fibrosis (IPF) is still unknown. We developed a practical in silico screening approach for the characterization of RBPs using multi-sources data information and comparative molecular network bioinformatics followed by wet-lab validation studies. Data mining of bulk RNA-Sequencing data of tissues of patients with IPF identified Quaking (QKI) as a significant downregulated RBP. Cell-type specific expression was confirmed by single-cell RNA-Sequencing analysis of IPF patient data. We systematically analyzed the molecular interaction network around QKI and its functional interplay with microRNAs (miRs) in human lung fibroblasts and discovered a novel regulatory miR-506-QKI axis contributing to the pathogenesis of IPF. The in silico results were validated by in-house experiments applying model systems of miR and lung biology. This study supports an understanding of the intrinsic molecular mechanisms of IPF regulated by the miR-506-QKI axis. Initially applied to human lung disease, the herein presented integrative in silico data mining approach can be adapted to other disease entities, underlining its practical relevance in RBP research.

Entities:  

Year:  2021        PMID: 34127686     DOI: 10.1038/s41598-021-89531-7

Source DB:  PubMed          Journal:  Sci Rep        ISSN: 2045-2322            Impact factor:   4.379


  25 in total

1.  DISEASES: text mining and data integration of disease-gene associations.

Authors:  Sune Pletscher-Frankild; Albert Pallejà; Kalliopi Tsafou; Janos X Binder; Lars Juhl Jensen
Journal:  Methods       Date:  2014-12-05       Impact factor: 3.608

Review 2.  A brave new world of RNA-binding proteins.

Authors:  Matthias W Hentze; Alfredo Castello; Thomas Schwarzl; Thomas Preiss
Journal:  Nat Rev Mol Cell Biol       Date:  2018-01-17       Impact factor: 94.444

Review 3.  Idiopathic Pulmonary Fibrosis.

Authors:  David J Lederer; Fernando J Martinez
Journal:  N Engl J Med       Date:  2018-05-10       Impact factor: 91.245

Review 4.  Idiopathic pulmonary fibrosis.

Authors:  Luca Richeldi; Harold R Collard; Mark G Jones
Journal:  Lancet       Date:  2017-03-30       Impact factor: 79.321

5.  Heterogeneous gene expression signatures correspond to distinct lung pathologies and biomarkers of disease severity in idiopathic pulmonary fibrosis.

Authors:  Daryle J DePianto; Sanjay Chandriani; Alexander R Abbas; Guiquan Jia; Elsa N N'Diaye; Patrick Caplazi; Steven E Kauder; Sabyasachi Biswas; Satyajit K Karnik; Connie Ha; Zora Modrusan; Michael A Matthay; Jasleen Kukreja; Harold R Collard; Jackson G Egen; Paul J Wolters; Joseph R Arron
Journal:  Thorax       Date:  2014-09-12       Impact factor: 9.139

6.  Quaking Inhibits Doxorubicin-Mediated Cardiotoxicity Through Regulation of Cardiac Circular RNA Expression.

Authors:  Shashi Kumar Gupta; Ankita Garg; Christian Bär; Shambhabi Chatterjee; Ariana Foinquinos; Hendrik Milting; Katrin Streckfuß-Bömeke; Jan Fiedler; Thomas Thum
Journal:  Circ Res       Date:  2017-11-13       Impact factor: 17.367

7.  Cellular senescence mediates fibrotic pulmonary disease.

Authors:  Marissa J Schafer; Thomas A White; Koji Iijima; Andrew J Haak; Giovanni Ligresti; Elizabeth J Atkinson; Ann L Oberg; Jodie Birch; Hanna Salmonowicz; Yi Zhu; Daniel L Mazula; Robert W Brooks; Heike Fuhrmann-Stroissnigg; Tamar Pirtskhalava; Y S Prakash; Tamara Tchkonia; Paul D Robbins; Marie Christine Aubry; João F Passos; James L Kirkland; Daniel J Tschumperlin; Hirohito Kita; Nathan K LeBrasseur
Journal:  Nat Commun       Date:  2017-02-23       Impact factor: 14.919

8.  Widespread Translational Control of Fibrosis in the Human Heart by RNA-Binding Proteins.

Authors:  Sonia Chothani; Sebastian Schäfer; Eleonora Adami; Sivakumar Viswanathan; Anissa A Widjaja; Sarah R Langley; Jessie Tan; Mao Wang; Nicholas M Quaife; Chee Jian Pua; Giuseppe D'Agostino; Shamini Guna Shekeran; Benjamin L George; Stella Lim; Elaine Yiqun Cao; Sebastiaan van Heesch; Franziska Witte; Leanne E Felkin; Eleni G Christodoulou; Jinrui Dong; Susanne Blachut; Giannino Patone; Paul J R Barton; Norbert Hubner; Stuart A Cook; Owen J L Rackham
Journal:  Circulation       Date:  2019-07-09       Impact factor: 29.690

9.  Preclinical development of a miR-132 inhibitor for heart failure treatment.

Authors:  Ariana Foinquinos; Sandor Batkai; Celina Genschel; Janika Viereck; Steffen Rump; Mariann Gyöngyösi; Denise Traxler; Martin Riesenhuber; Andreas Spannbauer; Dominika Lukovic; Natalie Weber; Katrin Zlabinger; Ena Hašimbegović; Johannes Winkler; Jan Fiedler; Seema Dangwal; Martin Fischer; Jeanne de la Roche; Daniel Wojciechowski; Theresia Kraft; Rita Garamvölgyi; Sonja Neitzel; Shambhabi Chatterjee; Xiaoke Yin; Christian Bär; Manuel Mayr; Ke Xiao; Thomas Thum
Journal:  Nat Commun       Date:  2020-01-31       Impact factor: 14.919

10.  Senescence-induced inflammation: an important player and key therapeutic target in atherosclerosis.

Authors:  Stevan D Stojanović; Jan Fiedler; Johann Bauersachs; Thomas Thum; Daniel G Sedding
Journal:  Eur Heart J       Date:  2020-08-14       Impact factor: 29.983

View more
  1 in total

Review 1.  Alveolar Regeneration in COVID-19 Patients: A Network Perspective.

Authors:  Shishir K Gupta; Mugdha Srivastava; Rashmi Minocha; Aman Akash; Seema Dangwal; Thomas Dandekar
Journal:  Int J Mol Sci       Date:  2021-10-19       Impact factor: 5.923

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.